Cargando…
Targeting NAMPT as a therapeutic strategy against stroke
Stroke is the second and the leading most common cause of death in the world and China, respectively, but with few effective therapies. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD) salvage synthesis in mammals, thereby influen...
Autores principales: | Wang, Shu-Na, Miao, Chao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613878/ https://www.ncbi.nlm.nih.gov/pubmed/31338216 http://dx.doi.org/10.1136/svn-2018-000199 |
Ejemplares similares
-
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
por: Roulston, Anne, et al.
Publicado: (2015) -
Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT
por: Wang, Xia, et al.
Publicado: (2015) -
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
por: Lin, Tsung-Chieh
Publicado: (2022) -
NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma
por: Guo, Qiuyun, et al.
Publicado: (2019) -
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
por: Indini, Alice, et al.
Publicado: (2022)